Latest Stock Market News

“My skew has been more towards mid and smallcap generally and hence I advise investors to first have a long-term view. Do not look at the short-term volatility. It can be more volatile because these are smallcap segments but on a long-term curve, the volatility reduces and the return profile improves.”

Nifty has lost about 13 per cent from April highs due to a host of domestic and global factors, including mixed Q4 numbers from India Inc, rising inflation, crude oil prices, geopolitical worries and rate hikes.

"The bulls made a strong comeback after forming a triple bottom near the 15,74​0 level. However, the pullback was very short-lived as the Nifty once again faced stiff resistance around 16,400 levels.As highlighted earlier, the market had gone into extremely oversold territory and a pullback was very much due and we have witnessed the same."

With this, net outflow by Foreign Portfolio Investors (FPIs) from equities reached Rs 1.63 lakh crore so far in 2022.

"It is important to understand the difference between AI and ML. AI is the ability of a machine to replace human intelligence and be able to perform and enhance human-like tasks. Robots, chatbots etc. are all examples of AI use cases. ML is a subset of AI, where the machine has the ability to learn from data and draw inferences from it without explicit human assistance or rules."

Gold’s recovery materialized as the US dollar index came off the highs. The US dollar index hit a 2002 high earlier this month amid safe-haven buying and expectations that the US Fed may lead other central banks in tightening monetary policy to get inflation under control

This week the domestic market was moving in tandem with its global peers. The worries over global economic slowdown and rate hikes took control of the market sentiments, said Vinod Nair, Head of Research at Geojit Financial Services.

Mainly, there are two kinds of factors: Macroeconomic factors and Style factors. Macroeconomic factors which are not directly correlated with the financial assets yet affect their prices. For instance, GDP growth, Interest rate, Inflation, and so on.

I think still early days but normally pharma is a good defensive so in challenging times people do retreat to pharma but Indian pharma given the valuations in the growth phase also we saw it did not do so well I would be a little circumspect, not the time right now to get into pharma, said Ajay Bagga.

So long as it is above this zone, there will be higher chances of Nifty stabilising and finding a foot for itself. In other words, a violation of this zone will invite incremental weakness. To translate this in simpler terms, Nifty’s price action against 15000-15700 zone would be crucial to watch over the coming weeks.